IRVINE, Calif., Oct. 24 ISTA Pharmaceuticals, Inc. (Nasdaq: ISTA), today announced it will release third quarter 2008 financial results on October 30, 2008, and will host a conference call to discuss these results and provide a pipeline update at 10:00 a.m. Eastern Time.
To access the 24-hour audio replay, U.S. and Canadian participants may dial 888-286-8010; international participants may dial 617-801-6888. The access code for the replay is 20163809. This conference call also will be webcast live and archived on ISTA's website until November 30, 2008.
ISTA Pharmaceuticals is an ophthalmic pharmaceutical company. ISTA's products and product candidates addressing the $4.7 billion U.S. prescription ophthalmic industry include therapies for inflammation, ocular pain, glaucoma, allergy, and dry eye. The Company currently markets three products and is developing a strong product pipeline to fuel future growth and market share. The Company's product development and commercialization strategy is to launch a new product every 12 to 18 months, thereby continuing its growth to become the leading niche ophthalmic pharmaceutical company in the U.S. For additional information regarding ISTA, please visit ISTA Pharmaceuticals' website at http://www.istavision.com.
Date: Thursday, October 30, 2008 Time: 10:00 a.m. Eastern Time Conference call access: Internet: www.istavision.com Domestic dial-in: 800-260-8140 International dial-in: 617-614-3672 Passcode: 73172859
SOURCE ISTA Pharmaceuticals, Inc.